DRW Securities’s Albireo Pharma Inc ALBO Stock Holding History

DRW Securities’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,000	Closed	-$320K	–	107
2018 Q2	$320K	Buy	+9,000	New	+$292K	0.02%	47

Other funds holding ALBO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

DRW Securities's ALBO Position: Q3 2018 in Review

DRW Securities sold out of Albireo Pharma Inc (ALBO) in Q3 2018, closing a stake of 9,000 shares — an estimated $320K sold.

DRW Securities first reported a position in ALBO in Q2 2018 and held it in 1 quarter. The position peaked at $320K in Q2 2018. 67 funds tracked by Wall St. Rank hold ALBO as of Q3 2018.

DRW Securities reported no remaining Albireo Pharma Inc position as of Q3 2018 after selling out during the quarter.
DRW Securities sold 9,000 Albireo Pharma Inc shares in Q3 2018, an estimated $320K.
DRW Securities first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 1 quarter.
DRW Securities's Albireo Pharma Inc position peaked at $320K in Q2 2018.
67 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2018.

Based on DRW Securities's 13F filing for Q3 2018, filed 14 Nov 2018.